In this interview, Richard J. Nowak, MD, MS, principal investigator of the MINT trial of inebilizumab for generalized myasthenia gravis (gMG), discusses the trial’s key findings, including significant ...

The myasthenia gravis (MG) market across the seven major markets (7MM: France, Germany, Italy, Japan, Spain, the UK and the ...

The exact way Ultomiris works to treat myasthenia gravis isn’t fully understood. But it’s thought to involve the medication’s ability to block the activity of a complement system protein ...

20 Kupersmith MJ, Latkany R, Homel P. Development of generalized disease at 2 years in patients with ocular myasthenia gravis. Arch Neurol. 2003 Feb;60(2):243-8. doi: 10.1001/archneur.60.2.243 ...

New compelling results demonstrate 18 months of both sustained reduction in immunoglobulin G antibodies and sustained improvement in gMG symptoms in pivotal Vivacity-MG3 study and open-label ...

Myasthenia gravis (MG) results from ... Antibodies to AChR are most common; they account for about 80% of generalized MG cases and half of ocular MG cases. ... Treatment Implications.

This is called ocular myasthenia. ... Most people with myasthenia gravis need medication that slows down the immune system. At first, you may get strong steroids like prednisone.

ABOUT GENERALIZED MYASTHENIA GRAVIS (gMG)Myasthenia gravis (MG) is an autoantibody disease in which the immune system mistakenly makes antibodies (e.g., anti-acetylcholine receptor [AChR], anti ...

Biologics License Application acceptance supported by results from the Phase 3 Vivacity-MG3 study Results demonstrate sustained disease control over 24 weeks in a broad population of antibody ...

Results demonstrate sustained disease control over 24 weeks in a broad population of antibody positive adult patients: anti-AChR, anti-MuSK, anti-LRP4 SPRING HOUSE, Pa., Jan. 9, 2025 /PRNewswire ...

New myasthenia gravis (MG) research continues to evaluate the subtleties of clinical and serological differences between ocular MG and generalized MG, with conclusions of a recent retrospective ...